Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-106328

Chief Development Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-02 Grant or award : show line 1 in the form +100,000 215,984 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-02 Grant or award : show line 2 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X05/tm2425639-4_4seq1.xml…